169 related articles for article (PubMed ID: 23720171)
1. [Diabetes and the liver].
Herzig S; Roden M
Dtsch Med Wochenschr; 2013 Jun; 138(23):1204-6. PubMed ID: 23720171
[No Abstract] [Full Text] [Related]
2. Obesity and the liver: developmental perspectives.
Hoppin AG
Semin Liver Dis; 2004 Nov; 24(4):381-7. PubMed ID: 15605306
[TBL] [Abstract][Full Text] [Related]
3. [Obesity related complications in children and adolescents].
Fichna P; Skowrońska B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):223-8. PubMed ID: 17020660
[TBL] [Abstract][Full Text] [Related]
4. The relation of insulin resistance syndromes to risk of cardiovascular disease.
Nesto RW
Rev Cardiovasc Med; 2003; 4 Suppl 6():S11-8. PubMed ID: 14668699
[TBL] [Abstract][Full Text] [Related]
5. Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution.
Bozzetto L; Prinster A; Mancini M; Giacco R; De Natale C; Salvatore M; Riccardi G; Rivellese AA; Annuzzi G
Eur J Clin Invest; 2011 Jan; 41(1):39-44. PubMed ID: 20825466
[TBL] [Abstract][Full Text] [Related]
6. Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group III: worldwide comorbidities of obesity.
Caterson ID; Hubbard V; Bray GA; Grunstein R; Hansen BC; Hong Y; Labarthe D; Seidell JC; Smith SC;
Circulation; 2004 Nov; 110(18):e476-83. PubMed ID: 15520332
[No Abstract] [Full Text] [Related]
7. Fatty liver disease in obese children--relation to other metabolic risk factors.
Volovelsky O; Weiss R
Int J Pediatr Obes; 2011 Sep; 6 Suppl 1():59-64. PubMed ID: 21905818
[TBL] [Abstract][Full Text] [Related]
8. Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management.
Byrne CD
Diabet Med; 2012 Sep; 29(9):1098-107. PubMed ID: 22672330
[TBL] [Abstract][Full Text] [Related]
9. Adipose tissue dysfunction in obesity.
Blüher M
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
[TBL] [Abstract][Full Text] [Related]
10. Serving diabetes and cardiology: round three of the South African diabetologist/cardiologist debate.
Aalbers J
Cardiovasc J Afr; 2011; 22(3):161-3. PubMed ID: 21713308
[No Abstract] [Full Text] [Related]
11. The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women--a hyperinsulinemic euglycemic insulin clamp study.
Saruç M; Yüceyar H; Ayhan S; Türkel N; Tuzcuoglu I; Can M
Hepatogastroenterology; 2003; 50(51):771-4. PubMed ID: 12828082
[TBL] [Abstract][Full Text] [Related]
12. Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus.
Hodge AM; Dowse GK; Zimmet PZ
Diabet Med; 1996 May; 13(5):441-9. PubMed ID: 8737026
[TBL] [Abstract][Full Text] [Related]
13. Impact of diabetes on the severity of liver disease.
Hickman IJ; Macdonald GA
Am J Med; 2007 Oct; 120(10):829-34. PubMed ID: 17904449
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic steatohepatitis: a review of the literature and updates in management.
Pasumarthy L; Srour J
South Med J; 2010 Jun; 103(6):547-50. PubMed ID: 20710138
[TBL] [Abstract][Full Text] [Related]
15. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance.
Weyer C; Foley JE; Bogardus C; Tataranni PA; Pratley RE
Diabetologia; 2000 Dec; 43(12):1498-506. PubMed ID: 11151758
[TBL] [Abstract][Full Text] [Related]
16. Gut response.
Bell H
Minn Med; 2008 Jun; 91(6):24-8. PubMed ID: 18616017
[No Abstract] [Full Text] [Related]
17. Insulin resistance in patients with polycystic ovary syndrome.
Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM
Ann Med; 2004; 36(6):426-39. PubMed ID: 15513294
[TBL] [Abstract][Full Text] [Related]
18. [Insulin resistance--possible causes and effects].
Bornkessel B
Med Monatsschr Pharm; 1996 Mar; 19(3):81-4. PubMed ID: 8868967
[No Abstract] [Full Text] [Related]
19. Postprandial insulin secretion pattern is associated with histological severity in non-alcoholic fatty liver disease patients without prior known diabetes mellitus.
Kimura Y; Hyogo H; Ishitobi T; Nabeshima Y; Arihiro K; Chayama K
J Gastroenterol Hepatol; 2011 Mar; 26(3):517-22. PubMed ID: 21054523
[TBL] [Abstract][Full Text] [Related]
20. Impact of non-alcoholic fatty liver disease on accelerated metabolic complications.
Fan JG
J Dig Dis; 2008 May; 9(2):63-7. PubMed ID: 18419637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
